Are endothelial progenitor cells a prognostic factor in patients with heart failure?

References

• Folkman J, Shing Y. Vasculaogenesis. J. Biol. Chem.267, 10931–10934 (1992).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275, 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med.7, 1194–1201 (2001).
   PubMed Web of Science ®Google Scholar
• Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B. Clin. Cytom.64(1), 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Civin CI, Banquerigo ML, Strauss LC, Loken MR. Antigenic analysis of haematopoiesis. VI. Flow cytometry characterization of cells in normal human bone marrow. Exp. Hematol.15, 10–17 (1987).
   PubMed Web of Science ®Google Scholar
• Delia D, Lampugnani MG, Resnati M et al. CD34 expression is regulated reciprocally with adhession molecules in vascular endothelial cells in vitro. Blood81, 1001–1008 (1993).
   PubMed Web of Science ®Google Scholar
• Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J. Pathol.214, 3–9 (2008).
   PubMed Web of Science ®Google Scholar
• Yin AH, Miraglia S, Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood90, 5002–5012 (1997).
   PubMed Web of Science ®Google Scholar
• Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene19, 5598–5605 (2000).
   PubMed Web of Science ®Google Scholar
• Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial late outgrowth from blood. J. Clin. Invest.105, 71–77 (2000).
   PubMed Web of Science ®Google Scholar
• George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng.12(2), 331–335 (2006).
   PubMedGoogle Scholar
• Case J, Mead LE, Bessler WK et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol.35(7), 1109–1118 (2007).
   PubMed Web of Science ®Google Scholar
• Aicher A, Rentsch M, Sasaki K et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res.100(4), 581–589 (2007).
   PubMed Web of Science ®Google Scholar
• Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J. Mol. Cell. Cadiol.50, 266–272 (2011).
   PubMed Web of Science ®Google Scholar
• Hur J, Yoon CH, Kim HS et al. Characterization of two types of endothelial progenitor cells and their different contribution to neovascularization. Arterioscler. Thromb. Vasc. Biol.24, 288–293 (2004).
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JPI et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N. Engl. J. Med.348, 593–600 (2003).
   PubMed Web of Science ®Google Scholar
• Yoder MC, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cells principals. Blood109(5), 1801–1809 (2007).
   PubMed Web of Science ®Google Scholar
• Yoon CH, Hur J, Park KW et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation112, 1618–1627 (2005).
   PubMed Web of Science ®Google Scholar
• Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann. Thorac. Surg.83, 598–605 (2007).
   PubMed Web of Science ®Google Scholar
• Dotsenko O, Xiao Q, Xu Q, Jahangiri M. Bone marrow resident and circulating progenitor cells in patients undergoing cardiac surgery. Ann. Thorac. Surg.90, 1944–1951 (2010).
   Google Scholar
• Massa M, Rosti V, Ferrario M et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood105, 199–206 (2005).
   PubMed Web of Science ®Google Scholar
• Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation103, 2776–2779 (2001).
   PubMed Web of Science ®Google Scholar
• Spevack DM, Cavaleri S, Zolotarev A et al. Increase in circulating bone marrow progenitor cells after myocardial infarction. Coron. Artery Dis.17, 345–349 (2006).
   Google Scholar
• Zhang L, Liu W, Chen Y, Song X, Jin Z, Lu S. Proliferation, migration and apoptosis activities of endothelial progenitor cells in acute coronary syndrome. Chin. Med. J.123(19), 2655–2661 (2010).
   Google Scholar
• Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ. Res.88, 167–174 (2001).
   PubMed Web of Science ®Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function. Nat. Med.7, 430–436 (2001).
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl Acad. Sci. USA98, 10344–10349 (2001).
   PubMed Web of Science ®Google Scholar
• Heeschen C, Lehmann R, Honold J et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation109, 1615–1622 (2004).
   PubMed Web of Science ®Google Scholar
• Cheng S, Cohen KS, Shaw SY et al. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation122, 1176–1182 (2010).
   Google Scholar
• Treasure CB, Vita JA, Cox DA et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation81, 772–779 (1990).
   PubMed Web of Science ®Google Scholar
• Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium dependent vasodilation is attenuated in patients with heart failure. Circulation84, 1589–1596 (1991).
   PubMed Web of Science ®Google Scholar
• Drexler H, Hayoz D, Munzel T et al. Endothelial function in chronic congestive heart failure. Am. J. Cardiol.69, 1596–1601 (1992).
   PubMed Web of Science ®Google Scholar
• Hayoz D, Drexler H, Munzel T et al. Flow-mediated arteriolar dilation is abnormal in congestive heart failure. Circulation87(Suppl. VII), 92–96 (1993).
   Google Scholar
• Dini FL, Ghiadoni L, Conti U et al. Coronary flow reserve in idiopathic dilated cardiomyopathy: relation with left ventricular wall stress, natriuretic peptides, and endothelial dysfunction. J. Am. Soc. Echocardiogr.22, 354–360 (2009).
   PubMed Web of Science ®Google Scholar
• Fischer D, Rossa S, Landmesser U et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur. Heart J.26, 65–69 (2005).
   PubMed Web of Science ®Google Scholar
• Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation111, 363–368 (2005).
   PubMed Web of Science ®Google Scholar
• Parodi O, De Maria R, Roubina E. Redox state, oxidative stress and endothelial dysfunction in heart failure: the puzzle of nitrate–thiol interaction. J. Cardiovasc. Med.8, 765–774 (2007).
   Google Scholar
• Valgimigli M, Rigolin GM, Fucili A et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation110, 1209–1212 (2004).
   PubMed Web of Science ®Google Scholar
• Dufour C, Corcione A, Svahn J et al. TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anaemia patients and TNF-α suppresses erythopoieisis in vitro. Blood102, 2053–2059 (2003).
   PubMed Web of Science ®Google Scholar
• Fritzenwanger M, Lorenz F, Jung C et al. Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure. Eur. J. Med. Res.14, 113–117 (2009).
   Google Scholar
• Nonaka-Sarukawa M, Yamamoto K, Aoki H et al. Circulating endothelial progenitor cells in congestive heart failure. Int. J. Cardiol.119, 344–348 (2007).
   PubMed Web of Science ®Google Scholar
• Jie KR, Van der Putten K, Bergevoet MWT et al. Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome. Heart97, 60–65 (2011).
   Google Scholar
• Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood103, 921–926 (2004).
   PubMed Web of Science ®Google Scholar
• George J, Goldstein E, Abashidze A et al. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI3-kinase-dependent manner. Cardiovasc. Res.68, 299–306 (2005).
   PubMed Web of Science ®Google Scholar
• Theiss HD, David R, Engelmann MG et al. Circulation of CD341 progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur. Heart J.28, 1258–1264 (2007).
   PubMed Web of Science ®Google Scholar
• Pelliccia F, Pasceria V, Cianfrocca C et al. Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction. Coron. Artery Dis.20, 303–308 (2009).
   PubMedGoogle Scholar
• Bulut D, Maier K, Bulut-Streich N, Borgel J, Hanaafeld C, Mugge A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J. Cardiac Fail.14, 336–340 (2008).
   PubMed Web of Science ®Google Scholar
• Carvalho VO, Ruiz MA, Bocchi EA, Carvalho VO, Guimaraes GV. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients. Cardiol. J.16(5), 426–431 (2009).
   Google Scholar
• Geft D, Schwartzenberg S, Rogowsky O et al. Circulating apoptotic progenitor cells in patients with congestive heart failure. PLoS One3(9), e3238 (2008).
   Google Scholar
• Tousoulis D, Andreou I, Tsiatas M et al. Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. Atherosclerosis214, 151–157 (2011).
   PubMedGoogle Scholar
• Sarto P, Balducci E, Balconi G et al. Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure. J. Cardiac. Fail.13, 701–708 (2007).
   PubMed Web of Science ®Google Scholar
• Craenenbroeck EM, Hoymans VY, Beckers PJ et al. Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res. Cardiol.105, 665–676 (2010).
   Google Scholar
• Shmilovich H, Ben-Shoshan J, Tal R et al. B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells. Tissue Eng. Part A15(9), 2741–2749 (2009).
   PubMed Web of Science ®Google Scholar
• Michowitz Y, Goldstein E, Wexler D et al. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart93, 1046–1050 (2007).
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation106(24), 3009–3017 (2002).
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med.355(12), 1222–1232 (2006).
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med.353, 999–1007 (2005).
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A et al. Increase in circulating progenitor cells by statins therapy in patients with stable coronary artery disease. Circulation103, 2885–2890 (2001).
   PubMed Web of Science ®Google Scholar
• Xiao Q, Kiechl S, Patel S et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis – results from a large population-based study. PLoS One2(10), e975 (2007).
   PubMed Web of Science ®Google Scholar